VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,000 | -68.8% | 200 | -52.4% | 0.00% | -50.0% |
| Q1 2022 | $16,000 | +14.3% | 420 | -4.3% | 0.00% | 0.0% |
| Q4 2021 | $14,000 | +7.7% | 439 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $13,000 | -13.3% | 439 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $15,000 | +7.1% | 439 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $14,000 | -12.5% | 439 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $16,000 | -5.9% | 439 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $17,000 | +142.9% | 439 | +119.5% | 0.00% | +100.0% |
| Q2 2020 | $7,000 | +40.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $5,000 | -16.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $6,000 | -50.0% | 200 | -54.2% | 0.00% | -50.0% |
| Q3 2019 | $12,000 | +9.1% | 437 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $11,000 | +175.0% | 437 | +118.5% | 0.00% | +100.0% |
| Q1 2019 | $4,000 | -81.8% | 200 | -79.8% | 0.00% | -75.0% |
| Q1 2018 | $22,000 | – | 988 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |